Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

22.82
Delayed Data
As of Jul 22
 -1.66 / -6.78%
Today’s Change
18.55
Today|||52-Week Range
263.81
-77.55%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Operating ActivitiesNet Income / Starting Line-51.5M48.2M-347.0M-372.9M
 
 
 
 
 
Depreciation639.8M617.1M602.5M746.8M
 
 
 
 
 
Total Other Cash Flow176.0M246.6M234.5M159.9M
 
 
 
 
 
Funds From Operations714.3M824.0M558.7M507.6M
 
 
 
 
 
Funds From/For Other Operating Expenses299.6M165.5M113.3M-50.2M
 
 
 
 
 
Net Cash Flow - Operating Activities414.6M658.4M445.4M557.8M
 
 
 
 
 
 
InvestingIncrease In Investments0.000.00-47.2M0.00
 
 
Decrease In Investments159.1M-1.1M-111.8M0.00
 
 
 
 
Capital Expenditures-47.3M-43.2M-78.9M-62.3M
 
 
 
 
 
Fixed Asset Disposal------6.3M
 
 
Net Assets From Acquisitions -13.2B581.8M-1.4B-48.7M
 
 
 
 
 
Other Investing - Uses10.3B258.3K-20.2M0.00
 
 
 
 
Net Cash Flow Investing-2.7B540.5M-1.5B-112.0M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.00-300.0K0.00
 
 
Long Term Borrowings4.9B-738.5M1.7B1.2B
 
 
 
 
 
Long Term Debt Reduction-3.4B194.9M-871.2M-425.6M
 
 
 
 
 
Net Proceeds Stock Sale14.3M-65.6M66.1M800.0K
 
 
 
 
 
Common Preferred Redeemed-50.2M2.5M-24.7M0.00
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing6.9M-5.0M33.7M0.00
 
 
 
 
Other Uses - Financing115.4M168.8M-23.1M535.7M
 
 
 
 
 
Net Cash Flow - Financing1.4B-780.6M293.5M259.5M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash2.9M-8.8M-7.9M7.8M
 
 
 
 
 
 
Net Change In Cash-906.4M418.4M-771.8M705.3M